Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Competitive LPS antagonist E-5531 suppresses LPS-mediated effects in vitro and in vivo

Dec. 9, 1998

Pharmacyclics' photoangioplasty a hot topic at RSNA

Dec. 9, 1998

Electroporation catheter safely and effectively delivers heparin to arterial wall

Dec. 8, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

LXR initiates preclinical development of second-generation analogue of Elirex

Dec. 4, 1998

Additional dose of 5G1.1-SC for phase IIb CPB study identified in phase I trial

Dec. 2, 1998

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Dec. 2, 1998

Preclinical study results indicate feasibility of long-term administration of antihypertensive drug

Dec. 2, 1998

Mechanism-of-action studies of nifekalant described

Dec. 2, 1998

LIPID study establishes efficacy of pravastatin in patients with lower cholesterol levels

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...